基本信息
浏览量:111
职业迁徙
个人简介
David A. Stevenson, MD is a physician board certified in both pediatrics and medical genetics. He completed his pediatric residency at the University of New Mexico and completed his medical genetics residency at the University of Utah.
Dr. Stevenson is the program director for the Combined Pediatric-Medical Genetics Residency Program and the Medical Genetics Residency Program at Stanford. He is actively involved in graduate medical education and developing innovative ways of training the next generation of medical geneticists. In addition, as co-director of the Genetic Testing Optimization Service, he focuses on researching best practices for genetic testing utilization.
Dr. Stevenson sees all types of individuals with various genetic disorders in his clinical practice. However, he has particular interests in disorders of the Ras/MAPK pathway which includes neurofibromatosis type 1, Noonan syndrome, CFC syndrome, and Costello syndrome. He also has expertise in evaluating individuals with vascular anomalies including hereditary hemorrhagic telangiectasia, and skeletal dysplasias. Dr. Stevenson is on the scientific advisory board for Prader-Willi Syndrome Association (PWSA) and has a focus on treating individuals with Prader-Willi syndrome. He has research interests in identifying clinical trial endpoints and is actively involved in clinical trials.
Dr. Stevenson is the program director for the Combined Pediatric-Medical Genetics Residency Program and the Medical Genetics Residency Program at Stanford. He is actively involved in graduate medical education and developing innovative ways of training the next generation of medical geneticists. In addition, as co-director of the Genetic Testing Optimization Service, he focuses on researching best practices for genetic testing utilization.
Dr. Stevenson sees all types of individuals with various genetic disorders in his clinical practice. However, he has particular interests in disorders of the Ras/MAPK pathway which includes neurofibromatosis type 1, Noonan syndrome, CFC syndrome, and Costello syndrome. He also has expertise in evaluating individuals with vascular anomalies including hereditary hemorrhagic telangiectasia, and skeletal dysplasias. Dr. Stevenson is on the scientific advisory board for Prader-Willi Syndrome Association (PWSA) and has a focus on treating individuals with Prader-Willi syndrome. He has research interests in identifying clinical trial endpoints and is actively involved in clinical trials.
研究兴趣
论文共 218 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Andrea M. Gross,Scott R. Plotkin,Nelson B. Watts,Michael J. Fisher,Laura J. Klesse,Andres J. Lessing, Miranda L. Mcmanus,A. Noelle Larson,Beverly Oberlander,Jonathan J. Rios, Herb Sarnoff,Brittany N. Simpson,
Emilia Stellacci, Jennefer N Carter,Luca Pannone,David Stevenson, Dorsa Moslehi, Serenella Venanzi,Undiagnosed Diseases Network,Jonathan A Bernstein,Marco Tartaglia,Simone Martinelli
American journal of medical genetics. Part App.e63627-e63627, (2024)
Chloe Alexa McGhee, Hamed Honari, Monica Siqueiros-Sanchez, Yaffa Serur, Eric K. van Staalduinen,David Stevenson, Jennifer L. Bruno, Mira Michelle Raman, Tamar Green
Egyptian Journal of Medical Human Geneticsno. 1 (2024): 1-6
Nicole M. Warrington,Tao Sun,Jingqin Luo,Robert C. McKinstry, Patricia C. Parkin, Sara Ganzhorn, Debra Spoljaric, Anne C. Albers, Amanda Merkelson,Douglas R. Stewart,David A. Stevenson,David Viskochil,
openalex(2023)
American journal of medical genetics. Part Ano. 4 (2023): e63483-e63483
The Journal of physiology (2023)
引用0浏览0WOS引用
0
0
JOURNAL OF PHYSIOLOGY-LONDON (2023)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn